Walleye Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.1M | Sell |
279,804
-72,410
| -21% | -$7.78M | 0.12% | 73 |
|
|
2025
Q1 | $35.5M | Sell |
352,214
-159,960
| -31% | -$16.1M | 0.16% | 43 |
|
|
2024
Q4 | $45.7M | Buy |
512,174
+1,724
| +0.3% | +$154K | 0.11% | 37 |
|
|
2024
Q3 | $42.8M | Buy |
510,450
+34,769
| +7% | +$2.91M | 0.09% | 31 |
|
|
2024
Q2 | $36.6M | Buy |
475,681
+49,284
| +12% | +$3.8M | 0.07% | 27 |
|
|
2024
Q1 | $29.2M | Sell |
426,397
-57,496
| -12% | -$3.94M | 0.05% | 50 |
|
|
2023
Q4 | $28M | Sell |
483,893
-30,361
| -6% | -$1.76M | 0.06% | 33 |
|
|
2023
Q3 | $27.2M | Buy |
514,254
+219,799
| +75% | +$11.6M | 0.07% | 29 |
|
|
2023
Q2 | $15.9M | Sell |
294,455
-54,726
| -16% | -$2.96M | 0.06% | 77 |
|
|
2023
Q1 | $17.5M | Buy |
349,181
+21,966
| +7% | +$1.1M | 0.26% | 53 |
|
|
2022
Q4 | $15.1M | Sell |
327,215
-11,790
| -3% | -$546K | 0.28% | 67 |
|
|
2022
Q3 | $13.1M | Buy |
339,005
+127,731
| +60% | +$4.95M | 0.25% | 70 |
|
|
2022
Q2 | $7.87M | Buy |
211,274
+113,875
| +117% | +$4.24M | 0.22% | 94 |
|
|
2022
Q1 | $4.31M | Sell |
97,399
-60,244
| -38% | -$2.67M | 0.12% | 176 |
|
|
2021
Q4 | $6.7M | Buy |
+157,643
| New | +$6.7M | 0.21% | 95 |
|
|
2021
Q3 | – | Sell |
-7,546
| Closed | -$323 | – | 1575 |
|
|
2021
Q2 | $323 | Sell |
7,546
-87,206
| -92% | -$3.73K | 0.01% | 883 |
|
|
2021
Q1 | $3.66K | Sell |
94,752
-5,315
| -5% | -$205 | 0.21% | 67 |
|
|
2020
Q4 | $3.6K | Buy |
+100,067
| New | +$3.6K | 0.24% | 58 |
|
|
2020
Q3 | – | Sell |
-9,185
| Closed | -$322K | – | 834 |
|
|
2020
Q2 | $322K | Buy |
+9,185
| New | +$322K | 0.07% | 319 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 699 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 551 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 539 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 408 |
|